Strategic Education Shares Slightly Lower Following Q3 Results-December 2024-www.financetom.com

Strategic Education Shares Slightly Lower Following Q3 Results

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Strategic Education Shares Slightly Lower Following Q3 Results

Nov 9, 2024 12:16 PM

10:03 AM EST, 11/07/2024 (MT Newswires) -- Strategic Education ( STRA ) shares were slightly lower in recent Thursday trading after the education services company posted Q3 results.

The company reported Q3 adjusted earnings of $1.16 per diluted share, up from $0.97 a year earlier.

Three analysts polled by Capital IQ expected $0.80.

Revenue for the quarter ended Sept. 30 was $306.0 million, up from $285.9 million a year earlier.

Three analysts surveyed by Capital IQ expected $301.5 million.

The company maintained its quarterly dividend of $0.60 per share, payable on Dec. 9 to shareholders of record on Dec. 2.

Price: 95.52, Change: -0.90, Percent Change: -0.93

Previous page： Nuvation Bio's Lung Cancer Drug Candidate Taletrectinib Gets FDA Priority Review Next page： Psyence Biomedical Expects to Raise $2 Million From Private Placement

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Nuvation Bio's Lung Cancer Drug Candidate Taletrectinib Gets FDA Priority Review

Dec 23, 2024

08:37 AM EST, 12/23/2024 (MT Newswires) -- Nuvation Bio ( NUVB ) said Monday the US Food and Drug Administration has accepted its new drug application for drug candidate taletrectinib intended for the treatment of non-small cell lung cancer. The FDA granted priority review and set a Prescription Drug User Fee Act goal date of June 23, Nuvation said. Nuvation...

Psyence Biomedical Expects to Raise $2 Million From Private Placement

Dec 23, 2024

08:40 AM EST, 12/23/2024 (MT Newswires) -- Psyence Biomedical ( PBM ) said Monday it has agreed to a private placement of 1 million common shares or pre-funded warrants, along with accompanying series A and series B warrants, priced at $2 each for expected gross proceeds of $2 million. The company said the series A warrants expire in five years,...

Toyota to build plant to produce EVs in China, Nikkei reports

Dec 23, 2024

TOKYO, Dec 23 (Reuters) - Toyota Motor ( TM ) has decided to build a new factory to produce electric vehicles in China, the Nikkei business daily reported on Monday. The company will produce its luxury car brand Lexus at a new plant in Shanghai, the Nikkei reported citing several sources. Toyota ( TM ) has worked in China via...

Brazil's Petrobras to sign deal for four new support vessels built locally

Dec 23, 2024

RIO DE JANEIRO (Reuters) - Brazil's Transpetro, a unit of state-run oil firm Petrobras, said on Monday that local shipbuilding firms Ecovix and Mac Laren had won a tender to build four new coastal vessels for $69.5 million per vessel. WHY IT'S IMPORTANT The bid is the first step of Petrobras' plan to renew its fleet of support vessels, and...